Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes
Open Access
- 1 June 2019
- journal article
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 3 (6) , 236-253
Abstract
Dendritic cells (DCs) are crucial for the production of adaptive immune responses to disease-causing microbes. However, in the steady state (i.e., in the absence of an infection or when Ags are experimentally delivered without a DC-activating adjuvant), DCs present Ags to T cells in a tolerogenic manner and are important for the establishment of peripheral tolerance. Delivery of islet Ags to DCs using Ag-linked Abs to the DC endocytic receptor CD205 has shown promise in the NOD mouse model of type 1 diabetes (T1D). It is important to note, however, that all myeloid DCs express CD205 in humans, whereas in mice, only one of the classical DC subsets does (classical DC1; CD8α+ in spleen). Thus, the evaluation of CD205-targeted treatments in mice will likely not accurately predict the results observed in humans. To overcome this challenge, we have developed and characterized a novel NOD mouse model in which all myeloid DCs transgenically express human CD205 (hCD205). This NOD.hCD205 strain displays a similar T1D incidence profile to standard NOD mice. The presence of the transgene does not alter DC development, phenotype, or function. Importantly, the DCs are able to process and present Ags delivered via hCD205. Because Ags taken up via hCD205 can be presented on both class I and class II MHC, both CD4+ and CD8+ T cells can be modulated. As both T cell subsets are important for T1D pathogenesis, NOD.hCD205 mice represent a unique, patient-relevant tool for the development and optimization of DC-directed T1D therapies.Keywords
This publication has 66 references indexed in Scilit:
- Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentationJournal of Experimental Medicine, 2013
- Specialized role of migratory dendritic cells in peripheral tolerance inductionJournal of Clinical Investigation, 2013
- New and future immunomodulatory therapy in type 1 diabetesTrends in Molecular Medicine, 2012
- Specificity and detection of insulin-reactive CD4+T cells in type 1 diabetes in the nonobese diabetic (NOD) mouseProceedings of the National Academy of Sciences, 2011
- T‐cell autoantigens in the non‐obese diabetic mouse model of autoimmune diabetesImmunology, 2010
- Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulinGenes & Immunity, 2010
- Efficient culture of CD8+ T cells from the islets of NOD mice and their use for the study of autoreactive specificitiesJournal of Immunological Methods, 2008
- Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD miceProceedings of the National Academy of Sciences, 2008
- Differential Antigen Processing by Dendritic Cell Subsets in VivoScience, 2007
- Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathwayJournal of Experimental Medicine, 2006